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Vitamin A and non-epithelial tumours
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There has been considerable interest over the last
few years in the protective effect of vitamin A
against carcinogenesis. Much of the interest
stemmed from the fact that vitamin A has
profound effects on the differentiation of
epithelium, tissues in which more than 90% of
human malignancies arise. Human studies of
vitamin A and cancer have therefore concentrated
on epithelial tumours, and a number of case/control
studies have demonstrated lower levels of serum
retinol and B-carotene in cancer patients (Peto et
al., 1981). In addition, 2 prospective studies have
shown lower levels of serum retinol in patients
subsequently developing cancer (Wald et al., 1980,
Kark et al., 1981). However, recent studies have
failed to confirm a relationship between serum
retinol (Willett et al., 1984; Wald et al., 1984), or
retinol binding protein (RBP) and total carotenoids
with the subsequent development of tumours
(Willett et al., 1984). An alternative explanation for
the lower levels is that they are a consequence of
the presence of the malignancy, an hypothesis
supported by an observed relationship with the
stage of the disease (Chaudhy et al., 1980; Tyler
1984). To further investigate the relationship
between serum levels of retinol and carotenoids
with malignancy we have undertaken a pilot study
to determine whether or not similar differences
occur in patients with non-epithelial malignant
tumours. In addition, we have measured the levels
of retinol transport proteins in the serum in order
to ascertain whether any observed low values for
retinol were due to a dietary vitamin A
insufficiency.
The study group consisted of 31 patients, 14 male
and 17 female, with non-disseminated non-epithelial
tumours admitted for surgery to the Royal
Marsden hospital during a 12 month period in
1983/1984. There were 15 soft-tissue sarcomas, 1
osteogenic sarcoma and 15 malignant melanomas; 5
of the sarcoma patients had bulky local or nodal
recurrent disease, and 11 of the melanoma patients
were admitted for block dissection of stage 2
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disease. Fasting pre-operative venous blood was
obtained from the study group and from a control
group of similar age and sex with non-malignant
gynaecological or urological disease. Serum retinol
was measured using a modification of the
fluorometric method of Hansen & Warwick (1978)
and van Stevenick & De Goeij (1973). Serum
carotenoids were determined spectrophotometrically
(Neeld & Pearson 1963). Serum RBP and pre-
albumin were determined by the single radial
immunodiffusion technique (Mancini et al., 1965).
Although the fluorometric method for measuring
serum retinol has recently been criticised
(Thompson, 1983) the validity of the results in this
study has been confirmed by a close and highly
significant correlation with serum RBP (Smith &
Goodman 1971) (Figure 1).
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Figure 1 Relationship between serum concentrations
of retinol and retinol binding protein. (0) Sarcomas,
r=0.92, P=0.001; (A) Malignant melanomas,
r=0.923, P=0.001; (0) Controls, r=0.696, P=0.001.
The line represents the correlation between values in
all 3 groups, with a coefficient of correlation r=0.848
and significance P<0.001 using Student's t test
y=8.7x+ 18.9.
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The results are shown in Table I. En the sarcoma
patients, serum levels of retinol, pre-albumin, and
RBP were significantly lower than in the controls,
with significances P<0.01, P<0.001 and P=0.001
respectively. Serum carotenoids were also
significantly lower than in controls, although to a
lesser extent with P<0.05. In the malignant
melanoma patients, serum levels of carotenoids and
pre-albumin were significantly lower than in
controls with significance P<0.05.
Table I Variation in serum concentrations of
retinol, carotenoids, prealbumin and retinol
binding protein.
Malignant
Sarcomas melanomas Controls
Age 47.3 52.2 51.5
(years) +4.8 +2.9 +2.9
Retinol 63b 73 79
(pglOOml-') +5.5 +8.1 +3.5
Carotenoids 76a 75a 101
(glOOml-1) +9.4 +10.4 +7.5
Prealbumin 21.0d 24.8a 31.1
(mglOOml-) +2.3 +3.2 +1.2
RBP 4.9c 6.1 7.0
(mglOOml-) +0.5 + 1.0 +0.4
Results are expressed as mean values +s.e.
Statistical evaluation was performed using
Student's unpaired t test with one tailed
probability.
a-dsignificantly lower than controls:
bp <0.05.
CP<0.0.
0.001 .
The relevance of the reduced levels of vitamin A
found in cancer patients remains uncertain. The
most interesting finding of this present study is that
reduced levels of serum retinol and carotenoids are
not restricted to patients with epithelial tumours. In
addition, the study has demonstrated reduced levels
of the transport proteins pre-albumin and RBP in
patients with non-epithelial tumours. This suggests
that, for retinol, the reduced levels of vitamin are
not due to dietary deficiency, since a reduced intake
of vitamin A would tend to result in an increase
rather than a decrease of serum levels of transport
proteins (Navab et al., 1977). Only 1 of the 31
patients in the study had a history of weight loss,
and it is unlikely that the low levels of transport
proteins were due to protein malnutrition. An
alternative explanation for these results is that the
lower levels of retinol in our study group are
secondary to the lower levels of transport proteins,
occurring perhaps as a consequence of the presence
of malignancy due to altered protein biosynthesis in
the liver (Milano et al., 1978). The retrospective
nature of this study prevents any conclusion being
drawn as to whether the low levels of vitamin A
predisposed to the development of the malignant
disease, or were rather consequent upon its
presence. Further study is required to elucidate the
exact relationship between vitamin A and its
transport proteins with epithelial and non-epithelial
tumours, but the preliminary data presented here
may need to be taken into consideration in
constructing any hypothesis to explain the observed
association of vitamin A with cancer.
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